Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$71.4M |
| 2 |
Merck
MRK
|
+$69M |
| 3 |
Caterpillar
CAT
|
+$65.2M |
| 4 |
Cardinal Health
CAH
|
+$61.3M |
| 5 |
American Airlines Group
AAL
|
+$40.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$54.6M |
| 2 |
CA
CA, Inc.
CA
|
+$48.3M |
| 3 |
Ameren
AEE
|
+$46.3M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$35.9M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$34.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.71% |
| 2 | Healthcare | 13.53% |
| 3 | Technology | 12.95% |
| 4 | Industrials | 11.24% |
| 5 | Energy | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LGF
2476
DELISTED
Lions Gate Entertainment
LGF
| $731K | ﹤0.01% |
25,575
+7,084
| +38% | +$191K |
|
2477
NN Inc
NNBR
$274M
| $730K | ﹤0.01% |
28,500
+4,200
| +17% | +$95.1K |
|
2478
iShares Russell 1000 Growth ETF
IWF
$123B
| $728K | ﹤0.01% |
32,000
| – | – |
|
|
INWK
2479
DELISTED
InnerWorkings, Inc.
INWK
| $728K | ﹤0.01% |
85,596
-14,831
| -15% | -$111K |
|
2480
StoneX
SNEX
$9.3B
| $727K | ﹤0.01% |
184,685
-1,215
| -0.7% | -$4.53K |
|
2481
PC Connection
CNXN
$2.18B
| $725K | ﹤0.01% |
35,045
-320
| -0.9% | -$6.59K |
|
|
BDSI
2482
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $725K | ﹤0.01% |
60,000
+10,500
| +21% | +$99.5K |
|
2483
Prothena Corp
PRTA
$435M
| $724K | ﹤0.01% |
32,100
+11,600
| +57% | +$290K |
|
|
NATL
2484
DELISTED
National Interstate Corporation
NATL
| $724K | ﹤0.01% |
25,832
-226
| -0.9% | -$6.36K |
|
|
IMMU
2485
DELISTED
Immunomedics Inc
IMMU
| $719K | ﹤0.01% |
196,748
+67,448
| +52% | +$248K |
|
2486
RE/MAX Holdings
RMAX
$195M
| $718K | ﹤0.01% |
24,240
+7,440
| +44% | +$211K |
|
2487
RingCentral
RNG
$4.78B
| $717K | ﹤0.01% |
47,376
+28,472
| +151% | +$413K |
|
|
ENZ
2488
DELISTED
Enzo Biochem, Inc.
ENZ
| $717K | ﹤0.01% |
136,391
+28,050
| +26% | +$121K |
|
|
PETX
2489
DELISTED
Aratana Therapeutics, Inc.
PETX
| $717K | ﹤0.01% |
+45,900
| New | +$650K |
|
|
VIRX
2490
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $716K | ﹤0.01% |
523
+88
| +20% | +$102K |
|
|
PHLT
2491
DELISTED
Performant Healthcare Inc
PHLT
| $714K | ﹤0.01% |
70,641
+1,655
| +2% | +$15.1K |
|
2492
Republic Bancorp
RBCAA
$1.96B
| $711K | ﹤0.01% |
29,959
-208
| -0.7% | -$4.87K |
|
|
LIOX
2493
DELISTED
Lionbridge Technologies
LIOX
| $710K | ﹤0.01% |
119,400
+17,400
| +17% | +$102K |
|
2494
Walker & Dunlop
WD
$1.77B
| $704K | ﹤0.01% |
49,856
-336
| -0.7% | -$5.13K |
|
|
LHCG
2495
DELISTED
LHC Group LLC
LHCG
| $703K | ﹤0.01% |
32,867
-240
| -0.7% | -$5.01K |
|
|
NES
2496
DELISTED
NUVERRA ENVIRONMENTAL INC NEW COM STK (DE)
NES
| $703K | ﹤0.01% |
34,937
-320
| -0.9% | -$5.68K |
|
2497
Phibro Animal Health
PAHC
$1.49B
| $701K | ﹤0.01% |
+31,921
| New | +$607K |
|
|
PHX
2498
DELISTED
PHX Minerals
PHX
| $701K | ﹤0.01% |
25,000
| – | – |
|
2499
Crawford & Co Class B
CRD.B
$497M
| $695K | ﹤0.01% |
68,938
+9,100
| +15% | +$95.6K |
|
|
FMI
2500
DELISTED
Foundation Medicine, Inc.
FMI
| $692K | ﹤0.01% |
25,666
+10,404
| +68% | +$264K |
|
Similar funds
Charles Schwab's Q2 2014 Portfolio in Review
As of Q2 2014, Charles Schwab held 3,240 positions worth $59.5B, up 6.6% from $55.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab's Q2 2014 filing shows 172 new, 1,725 increased, 966 reduced and 151 closed positions. Its largest new stake was Navient: 923,423 shares worth $16.4M. The largest sale was Boeing, an estimated $54.6M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
- Charles Schwab's largest Q2 2014 buy was Navient: 923,423 shares worth $16.4M.
- Charles Schwab added most to Citigroup in Q2 2014, an estimated $71.4M increase.
- Charles Schwab's biggest Q2 2014 reduction was Boeing, cutting an estimated $54.6M.
- Charles Schwab fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $29.8M.
- Charles Schwab's ten largest holdings make up 14% of its $59.5B portfolio in Q2 2014.
- Charles Schwab opened 172 new positions and closed 151 in Q2 2014.
- Charles Schwab's portfolio value rose 6.6% quarter-over-quarter to $59.5B.
Based on Charles Schwab's 13F filing for Q2 2014, filed 30 Jul 2014.